Figure 10.
Composite 6-month end point of death or myocardial (re-)infarction event rates for the GPIIb-IIIa interventional trials.
*EPISTENT trial groups compared with reference group of Placebo + Stent.
Abbreviations as in Figure 9. Reproduced with permission from Lincoff et al. JACC 2000;35:1103.